Hanping Feng Selected Research

Clostridium difficile toxB protein

1/2014	Utility of Clostridium difficile toxin B for inducing anti-tumor immunity.
1/2012	Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanping Feng Research Topics

Disease

12	Infections 06/2022 - 12/2006
10	Clostridium Infections 10/2020 - 01/2010
9	Neoplasms (Cancer) 01/2018 - 12/2002
6	Inflammation (Inflammations) 01/2018 - 05/2005
5	Diarrhea 06/2022 - 07/2011
4	Colitis 01/2018 - 07/2011
3	Intestinal Diseases (Diseases, Intestinal) 10/2020 - 07/2015
2	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 04/2015 - 03/2011
2	Toxemia 01/2015 - 02/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 05/2012
1	Pleural Effusion (Pleural Effusions) 06/2022
1	Dysbiosis 01/2022
1	Decompression Sickness (Bends) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Ulcerative Colitis 12/2017
1	Crohn Disease (Crohn's Disease) 12/2017
1	Brucellosis (Malta Fever) 04/2016
1	Melanoma (Melanoma, Malignant) 01/2014
1	Reinfection 09/2012
1	Weight Gain 09/2012
1	Botulism 01/2012
1	Paralysis (Palsy) 01/2012
1	Hemolytic-Uremic Syndrome 05/2008
1	Cryptosporidiosis 12/2006
1	Hereditary Angioedemas 05/2005
1	Leukemia 06/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2004

Drug/Important Bio-Agent (IBA)

14	trimethylaminocarboxyldihydroboran (TCDB)IBA 01/2019 - 01/2010
9	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 07/2011
5	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 01/2010
5	VaccinesIBA 04/2016 - 04/2003
4	CytokinesIBA 06/2022 - 01/2003
3	Proteins (Proteins, Gene)FDA Link 12/2017 - 04/2003
3	SolutionsIBA 06/2004 - 04/2003
2	AntitoxinsIBA 10/2020 - 02/2015
2	Neutralizing AntibodiesIBA 01/2020 - 01/2015
2	Clostridium difficile tcdA proteinIBA 01/2018 - 05/2012
2	Single-Domain AntibodiesIBA 10/2016 - 09/2014
2	ExotoxinsIBA 04/2015 - 01/2010
2	AntibodiesIBA 02/2015 - 01/2015
2	Clostridium difficile toxB proteinIBA 01/2014 - 01/2012
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 06/2003 - 01/2003
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2003 - 12/2002
1	Monoclonal AntibodiesIBA 10/2020
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Dextran SulfateIBA 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	SaltsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	Fimbriae Proteins (Pilin)IBA 01/2016
1	GlucosyltransferasesIBA 07/2015
1	EnzymesIBA 07/2015
1	bezlotoxumabIBA 02/2015
1	actoxumabIBA 02/2015
1	Vancomycin FDA LinkGeneric 09/2012
1	MBX-500IBA 09/2012
1	Immunotoxins (Immunotoxin)IBA 08/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2012
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 08/2010
1	InflammasomesIBA 08/2010
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 08/2010
1	Shiga Toxin (Shigella Toxin)IBA 05/2008
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 12/2006
1	SelectinsIBA 05/2005
1	BradykininIBA 05/2005
1	PerforinIBA 05/2005
1	Granzymes (Granzyme)IBA 05/2005
1	Imatinib Mesylate (Gleevec)FDA Link 06/2004
1	Interleukin-12 (IL 12)IBA 06/2003
1	Cancer VaccinesIBA 04/2003
1	glucose-regulated proteinsIBA 04/2003

Therapy/Procedure

4	Therapeutics 06/2022 - 05/2005
3	Immunotherapy 10/2020 - 04/2003
1	Parenteral Infusions 10/2020
1	Laparotomy 12/2017